Sep 2026
Clinical outcomes associated with glucagon-like peptide-1 receptor agonist therapy in patients with peripheral artery disease and diabetes.
In patients with PAD and diabetes, GLP1-RA exposure was associated with favorable clinical outcomes, and time-aligned analyses demonstrated a lower risk of all-cause mortality, while sustained GLP1-RA exposure was associated with lower MALE risk.
H. A. Khadija, M. Alnees, Ali Abdullah et al.
· Diabetes & Metabolism · 0 citations